Regeneron Pharmaceuticals, Inc.
ANTI-VEGF PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING THE SAME

Last updated:

Abstract:

The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.

Status:
Application
Type:

Utility

Filling date:

18 Aug 2020

Issue date:

10 Jun 2021